Craniopharyngioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults
Conditions:   Craniopharyngioma, Child;   Craniopharyngioma;   Recurrent Craniopharyngioma Interventions:   Drug: Nivolumab;   Drug: DAY101 Sponsors:   Sabine Mueller, MD, PhD;   Bristol-Myers Squibb;   Day One Biopharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2022 Category: Research Source Type: clinical trials

MEKTOVI ® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Conditions:   Adamantinous Craniopharyngioma;   Recurrent Adamantinomatous Craniopharyngioma Intervention:   Drug: Binimetinib Oral Tablet [Mektovi] Sponsors:   Nationwide Children's Hospital;   Children's Hospital Colorado Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials